Skip to main content
OpenTrials
Completed

NCT Number: NCT02288052

Consolidation of Motor Learning of Writing Skills and Its Related Brain Activity Changes in Parkinson's Disease

The basal ganglia play an important role in motor learning, especially during the consolidation phase of motor learning. This raises the question whether it is possible to sustain learning increments in a neurodegenerative condition such as Parkinson's disease (PD). The aim of this study is to gain knowledge on whether it is possible to relearn skills which are actually affected by PD, such as writing, and determine whether neuroplasticity is possible. In this randomized controlled study, PD patients will either follow intensive writing training or a placebo treatment (stretch and relaxation training) during 6 weeks. The writing training will focus on automatization (withstanding dual task interference), transfer to an untrained task and retention. The placebo program is aimed to reduce stiffness in the upper limbs and has been shown to be ineffective in PD. To date, it is unknown how neural networks change as a result of consolidation after a prolonged period of motor learning in PD. Therefore the second arm of this study will investigate, for the first time, changes in neural connectivity using brain imaging data to elucidate which neuroanatomical regions are involved in consolidation of learning in PD. Finally, DTI and resting state fMRI-analysis will complement insights into the neural changes as a result of learning.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Rehabilitation Sciences KU Leuven

Leuven, 3001, Belgium

About this study

This translational study is a monocentric Randomized Controlled Trial (RCT). The investigators will recruit 40 PD patients from the early Hoehn & Yahr stages. Patients will be randomly allocated to an experimental group (writing training) and a control group (stretch- and relaxation training). All patients will receive the same frequency and duration of intervention. After the training period, patients will be followed up for another 6 weeks. Patients will be tested in the ON-phase of the medication cycle at 3 occasions: before (T1) and after training (T2) and after a 6-week retention period (T3). At T1 & T2 participants will be tested at the behavioral & neural level. At T3 participants will only be tested at the behavioral level.

Motor performance will be measured using MRI-compatible touch sensitive tablets and pencils. This system allows registration and translation of writing movements into online-cursor movements on screen in and outside a scanner environment. Both patient groups will be compared during a behavioral test battery consisting of (i) a trained sequence with and without visual cues; (ii) an untrained sequence with and without visual cues to test transfer; and (iii) a trained dual task to test automatization. Visual cues will consist of differently colored target zones of different band widths, indicating the scale and accuracy of writing.

Functional MRI measurements will take place in a 3T MR Philips Intera scanner. Before scanning, subjects will undergo a training session in a dummy scanner to familiarize them with the scanner environment and task instructions. During the fMRI sessions, participants will perform a trained and untrained sequence, both with and without visual cues. To control for differences in movement speed, all participants will perform the tasks at the same frequency, defined by an auditory pace. In addition to the fMRI measurements, resting state fMRI and DTI will also be performed to reveal alterations of the structural and functional connectivity between critical regions.

Behavioral data will be recorded as xy-coordinates and pressure values at a sampling rate of 200Hz and with a spatial resolution of 32.5µm. Statistical analysis of the behavioral data will have a between-subject factor of group (experimental and placebo group) and a within-subject factor of time (before training, after training and after the retention period).

Image analysis will be performed with Statistical Parametric Mapping (SPM) software. The investigators will contrast for either decreased or increased activation, as different regions may show divergent changes related to learning and transfer, with group as a between-subject factor and time (before and after training) and task condition (trained with cues, trained without cues, untrained with cues and untrained without cues) as within-subject factors.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of PD based on the UK Brain Bank criteria
  • Hoehn & Yahr stage I (with impairments on the right side) and II in the on-phase
  • Without cognitive impairment (MMSE >24)
  • On stable medication
  • Right handed

Exclusion criteria

  • Deep Brain Stimulator
  • Other contra-indications for MR scanning
  • Colorblind

Treatment and study plan

Writing program

Behavioral

6 weeks of at-home training (5days/week, 30minutes/day) using both pen-and-paper exercises and exercises on a writing tablet.

Stretch & Relaxation program

Behavioral

6 weeks of at-home training (5days/week, 30minutes/day) using a DVD with exercises.

Primary outcomes

  1. Change from baseline in writing amplitude (cm) on tablet after 6 weeks of training

    Time frame: 6 weeks

    Analysis based on measurement of XYZ coordinates, measured at a spatial resolution of 32.5 μm.

  2. Change from baseline in writing amplitude (cm) on tablet after 12 weeks, including 6 weeks without training

    Time frame: 12 weeks

    Analysis based on measurement of XYZ coordinates, measured at a spatial resolution of 32.5 μm.

  3. Change from baseline in brain activity during writing (functional MRI) after 6 weeks of training

    Time frame: 6 weeks

    Analysis of the change in Blood Oxygen Level Dependent (BOLD) response

  4. Change from baseline in brain activity during rest (resting state MRI) after 6 weeks of training

    Time frame: 6 weeks

    Analysis of the change in Blood Oxygen Level Dependent (BOLD) response

  5. Change from baseline in Diffusion Tensor Imaging after 6 weeks of training

    Time frame: 6 weeks

    Analysis of the change in Blood Oxygen Level Dependent (BOLD) response

Secondary outcomes

  1. Transfer of change in writing amplitude to an untrained writing sequence after 6 weeks of training

    Time frame: 6 weeks

    Analysis based on measurement of XYZ coordinates, measured at a spatial resolution of 32.5 μm.

  2. Transfer of change in writing amplitude to an untrained writing sequence after 12 weeks, including 6 weeks without training

    Time frame: 12 weeks

    Analysis based on measurement of XYZ coordinates, measured at a spatial resolution of 32.5 μm.

  3. Change from baseline in dual task effect (DTE) for writing amplitude after 6 weeks of training

    Time frame: 6 weeks

    Analysis of the DTE using the following formula: DTE= ((dual task amplitude-single task amplitude)/(single task amplitude))*100

  4. Change from baseline in dual task effect (DTE) for writing amplitude after 12 weeks, including 6 weeks without training

    Time frame: 12 weeks

    Analysis of the DTE using the following formula: DTE= ((dual task amplitude-single task amplitude)/(single task amplitude))*100

  5. Change from baseline in writing fluency (normalized jerk) on tablet after 6 weeks of training

    Time frame: 6 weeks

    Analysis based on measurement of XYZ coordinates, measured at a spatial resolution of 32.5 μm.

  6. Change from baseline in writing fluency (normalized jerk) on tablet after 12 weeks, including 6 weeks without training

    Time frame: 12 weeks

    Analysis based on measurement of XYZ coordinates, measured at a spatial resolution of 32.5 μm.

  7. Systematic Screening of handwriting difficulties (writing on paper) - change from baseline in quality score after 6 weeks of training

    Time frame: 6 weeks

    Analysis of the quality of handwriting based on different criteria (fluency in letter formation, connections between letters, regularity of letter height, space between words and straightness of the sentence).

  8. Systematic Screening of handwriting difficulties (writing on paper) - change from baseline in quality score after 12 weeks, including 6 weeks without training

    Time frame: 12 weeks

    Analysis of the quality of handwriting based on different criteria (fluency in letter formation, connections between letters, regularity of letter height, space between words and straightness of the sentence).

  9. Systematic Screening of handwriting difficulties (writing on paper) - change from baseline in writing speed after 6 weeks of training

    Time frame: 6 weeks

    Analysis of the number of letters written within a period of 5 minutes.

  10. Systematic Screening of handwriting difficulties (writing on paper) - change from baseline in writing speed after 12 weeks, including 6 weeks without training

    Time frame: 12 weeks

    Analysis of the number of letters written within a period of 5 minutes.

  11. Change from baseline in Purdue Pegboard test after 6 weeks of training

    Time frame: 6 weeks

    Analysis of the number of pegs placed within 30s.

  12. Change from baseline in Purdue Pegboard test after 12 weeks, including 6 weeks without training

    Time frame: 12 weeks

    Analysis of the number of pegs placed within 30s.

Sponsors and collaborators

Lead sponsor

KU Leuven

Other

Collaborators

  • Research Foundation Flanders

Registry information

Important dates

Study start
2013
Primary completion
2016
Study completion
2016
First posted
Nov 11, 2014
Registry last updated
Jan 28, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.